losargen-ht 50/12.5
30's (10's blister x 3) -
losargen-ht 50/12.5 50mg / 12.5mg / tablet
genqore drug store united arab emirates - 30's (10's blister x 3) - tablet - 50mg / 12.5mg / tablet - cardiovascular system-hypertension , heart failure
losargen-ht 50/12.5 50mg / 12.5mg / tablet
genqore drug store united arab emirates - 30's (10's blister x 3) - tablet - 50mg / 12.5mg / tablet - cardiovascular system-hypertension , heart failure
premarin 1.25mg tablets
pfizer ltd - conjugated oestrogens - oral tablet - 1.25mg
estrofem 2 mg
novo nordisk ltd., israel - estradiol as hemihydrate - film coated tablets - estradiol as hemihydrate 2 mg - estradiol - estradiol - hormone replacement therapy (hrt) for estrogen deficiency symptoms in postmenopausal women. prevention of osteoporosis in postmenopausal women at high risk of future fractures, who are tolerant of , or contraindicated for other medicinal products approved for the prevention of osteoporosis. estrofem is particularly for women who have been hysterectomized and therefore do not require combined estrogen/progestagen therapy.the experience treating women older than 65 years is limited.
estrofem 1 mg
novo nordisk ltd., israel - estradiol as hemihydrate - film coated tablets - estradiol as hemihydrate 1 mg - estradiol - estradiol - hormone replacement therapy (hrt) for estrogen deficiency symptoms in postmenopausal women. prevention of osteoporosis in postmenopausal women at high risk of future fractures, who are tolerant of , or contraindicated for other medicinal products approved for the prevention of osteoporosis. estrofem is particularly for women who have been hysterectomized and therefore do not require combined estrogen/progestagen therapy.the experience treating women older than 65 years is limited.
vagifem 10 mcg
novo nordisk ltd., israel - estradiol hemihydrate - film coated tablets - estradiol hemihydrate 10 mcg - estradiol - estradiol - treatment of atrophic vaginitis due to estrogen deficiency in postmenopausal women.the experience treating women older than 65 years is limited.שינוי משטר מינון: 1/7/2019שינויים בעלון לרופא בסעיף posology:4.2 posology and method of administrationvagifem is administered intravaginally as a local oestrogen therapy by use of an applicator. initial dose: one vaginal tablet daily for two weeks. maintenance dose: one vaginal tablet twice a week.treatment may be started on any convenient day.if a dose is forgotten, it should be taken as soon as the patient remembers. a double dose should be avoided.for initiation and continuation of treatment of postmenopausal symptoms, the lowest effective dose for the shortest duration (see also section 4.4) should be used.for oestrogen products for vaginal application of which the systemic exposure to the oestrogen remains within the normal postmenopausal range, such as vagifem, it is not recommended to add a progestagen (but see section 4.4, ‘special warnings and precautions for use’, ‘endometrial hyperplasia and carcinoma’).
nv readyserve oral progestagen for horses
ceva animal health pty ltd - altrenogest - oral solution/suspension - altrenogest steroid-progestin active 2.2 mg/ml - endocrine system - horse mare (female) | female horse - control of oestrus | control of ovulation
regumate oral progestagen for horses
intervet australia pty limited - altrenogest - oral solution/suspension - altrenogest steroid-progestin active 2.2 mg/ml - endocrine system - horse mare (female) | female horse - control of oestrus | control of ovulation
equimate oral progestagen for horses
abbey laboratories pty ltd - altrenogest - oral solution/suspension - altrenogest steroid-progestin active 2.2 mg/ml - endocrine system